0001209191-15-025334.txt : 20150311 0001209191-15-025334.hdr.sgml : 20150311 20150311183609 ACCESSION NUMBER: 0001209191-15-025334 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150309 FILED AS OF DATE: 20150311 DATE AS OF CHANGE: 20150311 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Revance Therapeutics, Inc. CENTRAL INDEX KEY: 0001479290 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770551645 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7555 GATEWAY BLVD. CITY: NEWARK STATE: CA ZIP: 94560 BUSINESS PHONE: 510-742-3400 MAIL ADDRESS: STREET 1: 7555 GATEWAY BLVD. CITY: NEWARK STATE: CA ZIP: 94560 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ruegg Curtis CENTRAL INDEX KEY: 0001597578 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36297 FILM NUMBER: 15693949 MAIL ADDRESS: STREET 1: 7555 GATEWAY BOULEVARD CITY: NEWARK STATE: CA ZIP: 94560 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-03-09 0 0001479290 Revance Therapeutics, Inc. RVNC 0001597578 Ruegg Curtis C/O REVANCE THERAPEUTICS, INC. 7555 GATEWAY BOULEVARD NEWARK CA 94560 0 1 0 0 EVP, Technical Operations Common Stock 2015-03-09 4 M 0 500 6.60 A 19837 D Common Stock 2015-03-09 4 S 0 500 18.00 D 19337 D Stock Option (Right to Buy) 6.60 2015-03-09 4 M 0 500 0.00 D 2016-05-15 Common Stock 500 3003 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 15, 2014. The Option is fully vested as of May 16, 2010. /s/ Gordon Ho, Attorney-in-fact 2015-03-11